Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes.

Although weak associations were noted between the AGE levels and tibial nerve CSA (β = 0.149), median nerve CMAP (β = −0.133), sural nerve SNAP (β = −0.102), sural nerve velocity (β = −0.117), and tibial nerve CMAP (β = −0.083), these relationships did not reach statistical significance.

also in 111,027 other papers